Immunotherapy for ovarian cancer: what are the targets of the future?

被引：12

作者：

Adams, Sarah F. ^{[1
]}

Benencia, Fabian ^{[2
]}

机构：

[1] Univ New Mexico, Ctr Canc, Gynecol Oncol, Albuquerque, NM 87131 USA

[2] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Acad Res Ctr 202C, Athens, OH 45701 USA

来源：

FUTURE ONCOLOGY | 2015年 / 11卷 / 09期

关键词：

chemotherapy; immunotherapy; ovarian cancer; tumor microenvironment; LIPOSOMAL DOXORUBICIN; T-CELLS;

D O I：

10.2217/fon.15.44

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1293 / 1296

页数：4

共 20 条

[1] Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18 [J].

Alagkiozidis, Ioannis ;

Facciabene, Andrea ;

Carpenito, Carmine ;

Benencia, Fabian ;

Jonak, Zdenka ;

Adams, Sarah ;

Carroll, Richard G. ;

Gimotty, Phyllis A. ;

Hammond, Rachel ;

Danet-Desnoyers, Gwen-aeel ;

June, Carl H. ;

Powell, Daniel J., Jr. ;

Coukos, George .

JOURNAL OF TRANSLATIONAL MEDICINE, 2009, 7

[2] Immunologic consequences of chemotherapy for ovarian cancer: Impaired responses to the influenza vaccine [J].

Chu, Christina S. ;

Boyer, Jean D. ;

Jawad, Abbas ;

Mcdonald, Kenyetta ;

Rogers, Wade T. ;

Prak, Eline T. Luning ;

Sullivan, Kathleen E. .

VACCINE, 2013, 31 (46) :5435-5442

[3] Tumor-infiltrating dendritic cell precursors recruited by a β-defensin contribute to vasculogenesis under the influence of Vegf-A [J].

Conejo-Garcia, JR ;

Benencia, F ;

Coureges, MC ;

Kang, E ;

Mohamed-Hadley, A ;

Buckanovich, RJ ;

Holtz, DO ;

Jenkins, A ;

Na, HN ;

Zhang, L ;

Wagner, DS ;

Katsaros, D ;

Caroll, R ;

Coukos, G .

NATURE MEDICINE, 2004, 10 (09) :950-958

[4] Plasmacytoid dendritic cells and regulatory T cells in the tumor microenvironment A dangerous liaison [J].

Conrad, Curdin ;

Gilliet, Michel .

ONCOIMMUNOLOGY, 2013, 2 (05)

[5] Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors [J].

Duraiswamy, Jaikumar ;

Kaluza, Karen M. ;

Freeman, Gordon J. ;

Coukos, George .

CANCER RESEARCH, 2013, 73 (12) :3591-3603

[6] Multifaceted Therapeutic Targeting of Ovarian Peritoneal Carcinomatosis Through Virus-induced Immunomodulation [J].

Gujar, Shashi ;

Dielschneider, Rebecca ;

Clements, Derek ;

Helson, Erin ;

Shmulevitz, Maya ;

Marcato, Paola ;

Pan, Da ;

Pan, Lu-zhe ;

Ahn, Dae-Gyun ;

Alawadhi, Abdulaziz ;

Lee, Patrick W. K. .

MOLECULAR THERAPY, 2013, 21 (02) :338-347

[7] IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer [J].

Hart, Kevin M. ;

Byrne, Katelyn T. ;

Molloy, Michael J. ;

Usherwood, Edward M. ;

Berwin, Brent .

FRONTIERS IN IMMUNOLOGY, 2011, 2

[8] Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity [J].

Huarte, Eduardo ;

Cubillos-Ruiz, Juan R. ;

Nesbeth, Yolanda C. ;

Scarlett, Uciane K. ;

Martinez, Diana G. ;

Buckanovich, Ronald J. ;

Benencia, Fabian ;

Stan, Radu V. ;

Keler, Tibor ;

Sarobe, Pablo ;

Sentman, Charles L. ;

Conejo-Garcia, Jose R. .

CANCER RESEARCH, 2008, 68 (18) :7684-7691

[9] T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia [J].

Kalos, Michael ;

Levine, Bruce L. ;

Porter, David L. ;

Katz, Sharyn ;

Grupp, Stephan A. ;

Bagg, Adam ;

June, Carl H. .

SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (95)

[10] A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer [J].

Kandalaft, Lana E. ;

Chiang, Cheryl L. ;

Tanyi, Janos ;

Motz, Greg ;

Balint, Klara ;

Mick, Rosemarie ;

Coukos, George .

JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11

← 1 2 →